Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.
about
Optimal Use of Vaccines for Control of Influenza A Virus in SwineDeveloping Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadExpression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based AssayModified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseasesAdvances in influenza vaccination.Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.A review of the changes to the licensing of influenza vaccines in Europe.Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.Immunosignatures can predict vaccine efficacy.Biological and protective properties of immune sera directed to the influenza virus neuraminidase.4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in GermanyAn Innovative Pseudotypes-Based Enzyme-Linked Lectin Assay for the Measurement of Functional Anti-Neuraminidase Antibodies.Influenza vaccines and vaccinations in Poland - past, present and future.Cross-reactive human B cell and T cell epitopes between influenza A and B viruses.Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins.No evidence for zoonotic transmission of H3N8 canine influenza virus among US adults occupationally exposed to dogs.MiR674 inhibits the neuraminidase-stimulated immune response on dendritic cells via down-regulated Mbnl3.Molecular characterization of neuraminidase genes of influenza A(H3N2) viruses circulating in Southwest India from 2009 to 2013.Genetic analysis of neuraminidase gene of influenza A(H1N1)pdm09 virus circulating in Southwest India from 2009 to 2012.Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.High-Yield Expression of M2e Peptide of Avian Influenza Virus H5N1 in Transgenic Duckweed Plants.Genome Hotspots for Nucleotide Substitutions and the Evolution of Influenza A (H1N1) Human Strains.Neuraminidase: Another Piece of the Influenza Vaccine Puzzle.Avian Influenza A Virus Pandemic Preparedness and Vaccine DevelopmentNeuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase SubtypeVaxArray potency assay for rapid assessment of "pandemic" influenza vaccines
P2860
Q26783503-90D03122-6D43-4E8F-A688-D46AFD1462D5Q26783897-40731038-63BF-494C-814E-C849ACE97134Q28547305-2FF1B7B1-EF7C-4B8F-BAAB-650AFDB29D23Q30209342-BC0F8E48-51B8-41A9-9AEF-B374295984E2Q30364315-0481C9A4-CB58-45DF-AB4F-377BC5CE6EFEQ30374446-40C3333B-0A43-446A-8419-EC2E48ABB936Q30379967-89F9D9A5-70E8-4E94-8AB9-72BC819C83BEQ30380287-F16B6CA4-1563-406C-BF89-DBAE3B687841Q30388390-B2E700E9-83C9-4864-A488-40526FC63014Q33820732-3D046E59-9288-48B8-838D-8FFBFC2D05A0Q34057785-9B846289-252A-4B8F-B44B-6B7AC4646BA8Q34380788-8FA8842F-6AA4-4F18-92FA-0FE1D8676CE4Q34991399-C4B8FC58-6720-4B7C-B439-C8355CB64DFCQ35200964-856C29F7-D6EE-4A1D-947E-1893898E1939Q35744237-68AF2BBA-321E-47CE-83E6-A8C160A71A16Q36576966-FD9211A9-E437-4085-BCD0-3115B9A808C5Q37053710-70923F89-CF99-4D28-86CD-C2A25FDEDB49Q37395095-502235C0-2C41-4BD0-B45D-DAE37B42D70CQ37423349-445F646A-8D35-4D4A-BBB7-E3A6C58E60CBQ37580153-FA9C2131-1193-4269-AF4D-BFEFDEF6334BQ38375680-BDC1940F-F52B-4E66-BB2B-A65CC0409AFBQ38379418-A9D2B085-8267-417D-A5F8-444F5766E3B4Q38804059-494ED0AB-43E2-42CD-82C5-B070921A5014Q41347626-8F6452B9-E606-466D-A101-1D9731AB1528Q41933365-2F5AC201-1CEC-4960-A4D2-51E5F6D8329EQ42157410-70C308A9-B7F6-4647-B9F8-4401B1F0854EQ42563202-F694097C-5913-4C8F-A060-1CC2C069BB3BQ51034194-1450B698-A478-4A69-B083-6F92935AC359Q56561344-192DC5BF-5474-4632-969C-4103B9269345Q57093905-F7251E97-5DB9-4BE7-9FB8-681C11A732F2Q57481875-1E27FC5F-74C4-4D03-9624-A46D704C10C4
P2860
Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Contribution of antibody produ ...... fforded by influenza vaccines.
@ast
Contribution of antibody produ ...... fforded by influenza vaccines.
@en
type
label
Contribution of antibody produ ...... fforded by influenza vaccines.
@ast
Contribution of antibody produ ...... fforded by influenza vaccines.
@en
prefLabel
Contribution of antibody produ ...... fforded by influenza vaccines.
@ast
Contribution of antibody produ ...... fforded by influenza vaccines.
@en
P2860
P356
P1476
Contribution of antibody produ ...... fforded by influenza vaccines.
@en
P2093
Glendie Marcelin
P2860
P304
P356
10.1002/RMV.1713
P577
2012-03-22T00:00:00Z